CVE-2017-2607
MEDIUMDescription
jenkins before versions 2.44, 2.32.2 is vulnerable to a persisted cross-site scripting vulnerability in console notes (SECURITY-382). Jenkins allows plugins to annotate build logs, adding new content or changing the presentation of existing content while the build is running. Malicious Jenkins users, or users with SCM access, could configure jobs or modify build scripts such that they print serialized console notes that perform cross-site scripting attacks on Jenkins users viewing the build logs.
How to fix
Remediation is compiled from vendor and distribution security advisories. Always confirm against the linked source for your exact version and platform.
CVSS v3 Vector
Exploitability
Impact
CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:N
Exploit Intelligence
Moderate risk: more likely to be exploited than 60% of all known CVEs.
References
Related Vulnerabilities
Other CWE-79 (Cross-Site Scripting (XSS)) vulnerabilities, ordered by exploit likelihood. View all
| CVE | Severity | CVSS | EPSS | Exploited | Fix |
|---|---|---|---|---|---|
| CVE-2020-11022 | Medium | 6.9 | 99% | - | Fix |
| CVE-2019-3929 | Critical | 9.8 | 99% | KEV | Fix |
| CVE-2020-9496 | Medium | 6.1 | 99% | - | - |
| CVE-2023-28341 | Medium | 6.1 | 99% | - | Fix |
| CVE-2018-12998 | Medium | 6.1 | 98% | - | - |
| CVE-2025-4123 | High | 7.6 | 98% | - | Fix |
Embed a live status badge for CVE-2017-2607
Markdown
[](https://tridentstack.com/cve/CVE-2017-2607)HTML
<a href="https://tridentstack.com/cve/CVE-2017-2607"><img src="https://tridentstack.com/cve/badge/CVE-2017-2607.svg" alt="CVE-2017-2607"></a>Find and fix vulnerabilities across your fleet
TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.
Start freeThis product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.